AgrenoX® Antiaggregant agent Capsules with modified release. Actylase® Fibrinolytic agent - plasminogen activator Liofilizate for the preparation of a solution for infusions complete with a solvent. Aptivus antiviral (HIV) agent Capsules 250 mg Atrovent® m-holinoblokator Solution for inhalation, 0.25 mg / ml. Atrovent® H m-holinoblokator Aerosol for inhalation dosed, 20 mcg / dose. Berodual® Bronchodilator combined (beta2-adrenomimetic selective + m-holinoblokator) Solution for inhalation, 0.25 mg + 0.5 mg / ml. Berodual® H Bronchodilator combined (beta2-adrenomimetic selective + m-holinoblokator) Aerosol for inhalation dosed, 20 mcg + 50 mcg / dose. Berotek® Bronchodilator - beta2-adrenomimetic selective Solution for inhalation, 0,1%. Berotek® H Bronchodilator - beta2-adrenomimetic selective Aerosol for inhalation dosed, 0.1 mg / dose. Buscopan® M-holinoblokator Suppositories rectal by 10 mg. Buscopan® M-holinoblokator The tablets covered with a cover of 10 mg. Vargatef® Antitumor agent - protein tyrosine kinase inhibitor Capsules 100, 150 mg. Viramune® Antiviral [HIV] agent Suspension for oral administration 50 mg / 5 ml. Viramune® Antiviral [HIV] agent Tablets 200 mg Gastrotsepin® M-holinoblokator Tablets 25 mg. Giotrif® Antitumor agent - protein tyrosine kinase inhibitor Tablets, film-coated 20 mg, 30 mg, 40 mg and 50 mg. Glycambi® Hypoglycemic agent for oral administration combined Tablets, film-coated, 5 mg 10 mg + 5 mg + 25 mg. Glyurenorm® Hypoglycemic agent for oral use of the second-generation sulfonylurea group. Tablets 30 mg. Guttalax® Laxative Tablets 5 mg. Guttalax® Laxative Drops for oral administration 7.5 mg / ml. Jardins® Hypoglycemic agent for oral administration Tablets, film-coated, 10 mg and 25 mg. Gentadueto A hypoglycemic agent for oral administration combined (dipeptidyl peptidase-4-inhibitor + biguanide) Tablets, film-coated, 2.5 mg + 500 mg / 2.5 mg + 850 mg / 2.5 mg + 1000 mg. Dulcolax® laxative Tablets, coated with enteric coating, 5 mg. Dulcolax® laxative Suppositories rectal, 10 mg. Mycardis® angiotensin II receptor antagonist. Tablets of 40 mg and 80 mg. MykardisPlus® antihypertensive drug combined (apogotenzin II receptor antagonist + diuretic). Tablets 12.5 / 40 mg and 12.5 / 80 mg. MykardisPlus® A combined hypotensive drug (angiotensin II receptor antagonist + diuretic) Tablets 25/80 mg. Mirapex® PD dopamine receptor agonist Tablets of prolonged action, 0.375 mg, 0.75 mg, 1.5 mg, 3.0 mg, 4.5 mg. Movalis® Non-steroidal anti-inflammatory drug - NSAIDs Suspension for oral administration 7.5 mg / 5 ml. Movalis® Non-steroidal anti-inflammatory drug - NSAIDs Solution for intramuscular injection 15 mg / 1.5 ml. Movalis® Non-steroidal anti-inflammatory drug - NSAIDs Tablets 7.5 mg or 15.0 mg. Movalis® Non-steroidal anti-inflammatory drug - NSAIDs. Suppositories rectal 15 mg. Pradaxa® Thrombin inhibitor direct Capsules, 75 mg, 110 mg and 150 mg. Pradaxa® Direct thrombin inhibitor Capsules 150 mg. Sinjardi Spiolto® Respimat® Bronchodilator combined (long-acting β2-adrenomimetic + m-holinoblokator) Solution for inhalation dosage 2.5 μg + 2.5 μg / dose. Spiriva® M-holinoblokator capsules with powder for inhalation 18 μg Spiriva® Respimat® M-holinoblokator Solution for inhalation 2.5 μg / dose Striverdi® Respimat® bronchodilator - beta2-adrenergic selective Solution for inhalation, 2.5 μg / dose. Twinsta® antihypertensive agent combined (blocker of "slow" calcium channels + angiotensin II receptor antagonist) Tablets 5 mg + 40 mg, 10 mg + 40 mg, 5 mg + 80 mg, 10 mg + 80 mg. Tragenta® Hypoglycemic agent - dipeptidyl peptidase-4 inhibitor (DPP-4) Film coated tablets 5 mg. Finalgel® Non-steroidal anti-inflammatory drug (NSAID) Gel for external use 0,5%. Finalgon® local irritant Ointment for external use. Finalgon® Local irritant Cream for external use.